// App-Quantinova.ai

P210 : Efficacy and safety of filgotinib for patients with RA with inadequate response to methotrexate: FINCH1 primary outcome results

Researchers

Presenter

  • David Walker

Principal Investigators

  • Bernard G Combe

  • Alan J Kivitiz

  • Yoshiya Tanaka

  • Dsire van der Heijde

  • Franziska Matzkies

  • Beatrix Bartok

  • Lie Ye

  • Ying Guo

  • Chantal Tasset

  • John S Sundy

  • Neelufar Mozaffarian

  • Robert B. M Landew

  • Sang-Cheol Bae

  • Edward C Keystone

  • Peter Nash

Medical Centers

  • Rheumatology, Northumbria Healthcare NHS Foundation Trust, Newcastle upon Tyne, UNITED KINGDOM

  • Rheumatology, CHU Montpellier, Montpellier University, Montpellier, FRANCE

  • Rheumatology, Altoona Center for Clinical Research, Altoona, PA, USA

  • Rheumatology, University of Occupational and Environmental Health, Kitakyushu, JAPAN

  • Rheumatology, Leiden University Medical Centre, Leiden, NETHERLANDS

  • Inflammation, Gilead Sciences, Foster City, CA, USA

  • Epidemiology, Gilead Sciences, Foster City, CA

  • Biostatistics, Gilead Sciences, Inc, Foster City, CA

  • Rheumatology, Galapagos NV, Mechelen, BELGIUM

  • Rheumatology, Amsterdam University Medical Center, Amsterdam, NETHERLANDS

  • Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, KOREA, REPUBLIC OF

  • Rheumatology, Mount Sinai Hospital and University of Toronto, Toronto, ON, CANADA

  • Rheumatology, University of Queensland, Brisbane, AUSTRALIA

Locations

  • United Kingdom

  • France

  • United States

  • Japan

  • Netherlands

  • Belgium

  • Republic of South Korea

  • Canada

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Methotrexate

  • Adalimumab

  • Filgotinib

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Superiority

  • Non Inferiority

  • Controlled

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved